RENAISSANCERE HOLDINGS LTD (RNR) stock intrinsic value fair value estimate & owner earnings analysis

RenaissanceRe is a Bermuda-based reinsurer: it sells insurance to insurance companies, taking on a slice of the catastrophe risk (hurricanes, earthquakes, wildfires) and other risk that primary insurers don't want to carry alone, in exchange for premium. It invests that premium (its "float") in a fixed-income and equity portfolio until claims come due. It also manages several third-party capital vehicles (DaVinci Re, Medici, Fontana, Upsilon and others) where outside investors put up additional capital alongside RenaissanceRe's own, for which the company earns fee and profit-share income. The business is inherently lumpy: any single year's results are driven heavily by whether major catastrophes happened to strike, not by the underlying quality of the underwriting. To value it fairly we looked at owner earnings (operating cash flow, adjusted for the swings in insurance reserves and receivables, less the true corporate cost of stock-based pay) across 2019 through 2025 — a stretch that includes a genuinely bad multi-year stretch (Hurricane Ida in 2021, Hurricane Ian and a sharp bond/equity market selloff in 2022) as well as three unusually strong years (2023–2025). In February 2023 the company acquired Validus Holdings, meaningfully increasing its scale and diversifying it into Lloyd's of London and additional casualty and specialty lines; 2025 was also the first year of a new 15% Bermuda corporate income tax, which is now a permanent part of the company's run rate. Because the business changed meaningfully with that acquisition, and the interest-rate environment underpinning investment income is now structurally higher than in 2019–2021, we set the starting point for our forward projections above the raw historical midpoint, while still discounting it well below the exceptionally strong 2023–2025 results, to leave room for reinsurance pricing softening from its recent highs and for casualty reserve risk (industry-wide "social inflation" in liability claims) that has not fully shown up yet. Our bear case assumes a severe, multi-driver stretch: a major hurricane or earthquake loss on the scale of the worst years in the company's history hits the now-larger book in the first year or two, reinsurance pricing turns soft as capital floods back into the sector (as happened in 2015–2017), and casualty reserves need strengthening for claims written in recent, more competitively priced years. Per-share owner earnings are roughly breakeven in the worst year and recover only gradually, settling at a modest but positive sustained level. Because that stress phase is short relative to a permanent business, more than two-thirds of the bear-case value comes from what the company is assumed to be capable of earning once conditions normalize — a assumption worth flagging plainly, though we think it's a reasonable one given the company's capital strength and underwriting record through past hard periods. Our base case assumes reinsurance pricing, which has been unusually favorable since the 2023 hard market, gradually softens over the next two to three years as competing capital returns, compressing margins somewhat before the business resumes modest growth from its larger, more diversified post-2023 base, share buybacks, and a fixed-income portfolio that continues to benefit from today's higher yields. Our bull case assumes today's favorable pricing and loss experience persist for longer than typical, with no major single catastrophe materially impairing results, continued reserve releases on prior accident years, and steady share buybacks compounding per-share value, roughly in line with the actual results the company has posted in each of the last three years. On these assumptions we estimate the shares are worth roughly $195 in the bear case, $430 in the base case, and $721 in the bull case, on a per-share basis. Given how wide that range is — reflecting real catastrophe and cycle risk rather than a lack of research — the margin-of-safety price sits at a meaningful discount to our base-case estimate, at roughly $268 per share. A few judgment calls worth noting. First, because RenaissanceRe consolidates capital vehicles that are substantially owned by outside investors, we scaled the company's operating cash flow down to the portion economically attributable to RenaissanceRe's own common shareholders each year, using the same year's split between income attributable to common shareholders and total consolidated income; this is an approximation in years where that split was unusual (2021, for instance, was a near-breakeven year for the whole company, which made the ratio noisy) but we think it is more accurate than treating 100% of consolidated cash flow as belonging to RenaissanceRe's shareholders. Second, unlike most companies we value, RenaissanceRe reports essentially no equipment or property spending at all in its cash flow statements in any year we reviewed — sensible for an insurer whose "assets" are underwriting relationships and capital, not factories — so we made no deduction for reinvestment. Third, mark-to-market gains and losses on the investment portfolio flow through reported net income but not through cash flow the same way; 2022's large reported loss, for example, overstates how much of a cash-flow-negative year it actually was once those non-cash marks are set aside, which is one reason our estimates rely on cash flow rather than reported earnings. We found nothing in the filings that could not be reconciled to the reported cash flow statements.